Brexpiprazole as an Additional Treatment to Paroxetine or Sertraline in Adult Patients Suffering From Post-traumatic Stress Disorder (PTSD)
Status: | Terminated |
---|---|
Conditions: | Psychiatric, Psychiatric, Psychiatric |
Therapuetic Areas: | Psychiatry / Psychology |
Healthy: | No |
Age Range: | 18 - 65 |
Updated: | 4/21/2016 |
Start Date: | December 2013 |
End Date: | October 2015 |
Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Flexible-dose Study of Brexpiprazole as Adjunctive Treatment to Paroxetine or Sertraline in Adult Patients Suffering From Post-traumatic Stress Disorder (PTSD)
To evaluate the efficacy of brexpiprazole as adjunctive treatment to paroxetine or
sertraline on PTSD symptoms.
sertraline on PTSD symptoms.
Inclusion Criteria:
- The patient has PTSD, diagnosed according to DSM-IV-TR™ and confirmed by the Mini
International Neuropsychiatric Interview (MINI).
- The patient has a pre-defined Clinician-Administered PTSD Scale Part 2 (CAPS-2) total
score at Screening and Baseline Visits.
- The reported duration of the PTSD is at least 3 months.
Exclusion Criteria:
- The index traumatic event that led to development of PTSD took place more than 15
years before screening.
- The patient has a severe personality disorder that in the investigator's opinion may
interfere with the conduct of the study.
- The patient is at significant suicidal risk.
Other inclusion and exclusion criteria may apply.
We found this trial at
23
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials